Pharmacogenetics, a clinical discipline in which doctors use high-tech genetic testing to custom-make drugs to patients’ individual needs, will mean that we define smaller and smaller markets for every drug.

Instead of one medication for high blood pressure, a manufacturer will have to produce dozens of variants and combinations.